BayOConnect 2026

BayOConnect 2026
Go back

Discover the future of biotechnology at BioM’s networking conference BayOConnect in Munich on 30 June – 1 July 2026!

This year, BayOConnect once again brings together visionary minds, cutting-edge companies and life-science enthusiasts from Bavaria and around Europe.

The 2026 edition will focus on

  • European capital and agenda to unlock biotech success stories
  • highlighting high-potential TechBio innovation and excellence initiatives in life sciences
  • as well as international collaboration within Europe and beyond

BayOConnect – Forum for Biotech & LifeScience

As a central platform, BayOConnect accelerates progress in biotechnology and medicine by creating direct exchange between science, industry, investors and policy leaders.

Join inspiring keynotes from academia and industry, panel discussions, dynamic start-up pitches, poster sessions and high-energy networking opportunities. Whether you’re driving biopharmaceutical innovation, exploring digital and AI-enabled solutions, building strategic partnerships or seeking investment insights, BayOConnect 2026 is your gateway into Bavaria’s vibrant biotech ecosystem.

Your Benefits:

  • Dive into the intersection of cutting-edge biopharmaceuticals, Artificial Intelligence, data science, nanotechnology and more.
  • Immerse yourself in dynamic keynotes, panel discussions, and a thrilling start-up pitch.
  • Connect with industry leaders, investors, visionary scientists via partnering system partneringONE™
  • Explore the potential of innovation in the heart of Europe’s biotech hub.

Don’t miss your chance to shape the future of biotech at BayOConnect 2026 right in Munich’s dynamic innovation landscape!

BioRN members receive a 15 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
European Biotech Act: bioRN brings Industry and Policymakers together

European Biotech Act: bioRN brings Industry and Policymakers together

How can Europe strengthen its global competitiveness in biotechnology? Heidelberg, July 7th: This question was at the heart of a high-level roundtable hosted by the bioRN Life Science Cluster with Member of the European Parliament Hildegard Bentele. Representatives from Ascendis Pharma, BD, PROGEN, Novaliq, BASF Agricultural Solutions, PEPperPRINT, Evotec and Isenbruck Bösl Hörschler joined the […]

read more
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

read more
Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp